SEC Form 4 · accession 0000891293-15-000010

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Finance & Administration

Period of report

Mar 20, 2015

Accepted (ET)

Mar 20, 2015 · 5:56 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 20, 2015	S	10,000	$1.92	D	1,075,152	D
Common Stock	Mar 20, 2015	S	1,300	$1.923	D	1,073,852	D
Common Stock	Mar 20, 2015	S	15,900	$1.93	D	1,057,952	D
Common Stock	Mar 20, 2015	S	17,100	$1.94	D	1,040,852	D
Common Stock	Mar 20, 2015	S	5,100	$1.943	D	1,035,752	D
Common Stock	Mar 20, 2015	S	11,500	$1.95	D	1,024,252	D
Common Stock	Mar 20, 2015	S	2,100	$1.96	D	1,022,152	D
Common Stock	holding	—	—		—	37	I	Trust for Children

No Table II lines on this filing.